$KNW
KNOW LABS, INC.

2024 Q3 Form 10-Q Financial Statement

#000165495424010633 Filed on August 14, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $2.487M
YoY Change 82.89%
% of Gross Profit
Research & Development $1.349M
YoY Change -28.23%
% of Gross Profit
Depreciation & Amortization $20.64K
YoY Change -62.09%
% of Gross Profit
Operating Expenses $3.836M
YoY Change 18.42%
Operating Profit -$3.836M
YoY Change 18.42%
Interest Expense $298.2K
YoY Change 1168.55%
% of Operating Profit
Other Income/Expense, Net -$267.6K
YoY Change -25.79%
Pretax Income -$4.103M
YoY Change 13.99%
Income Tax $0.00
% Of Pretax Income
Net Earnings -$4.103M
YoY Change 13.99%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share
COMMON SHARES
Basic Shares Outstanding 99.62M shares 85.51M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $2.130M
YoY Change -45.79%
Cash & Equivalents $3.111M $2.130M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $3.111M $2.130M
YoY Change -61.23% -45.79%
LONG-TERM ASSETS
Property, Plant & Equipment $66.80K $88.67K
YoY Change -17.87% -70.45%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $159.2K
YoY Change 909.77%
Total Long-Term Assets $553.7K $612.3K
YoY Change 128.62% 20.61%
TOTAL ASSETS
Total Short-Term Assets $3.111M $2.130M
Total Long-Term Assets $553.7K $612.3K
Total Assets $3.664M $2.742M
YoY Change -55.67% -38.19%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.256M
YoY Change 138.45%
Accrued Expenses $101.6K $116.7K
YoY Change 7.99% -71.97%
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change -100.0%
Long-Term Debt Due $4.540M
YoY Change
Total Short-Term Liabilities $5.163M $6.118M
YoY Change 14.18% 64.41%
LONG-TERM LIABILITIES
Long-Term Debt $945.3K
YoY Change
Other Long-Term Liabilities $280.7K
YoY Change
Total Long-Term Liabilities $1.226M
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $5.163M $6.118M
Total Long-Term Liabilities $1.226M
Total Liabilities $5.821M $7.344M
YoY Change 28.72% 97.35%
SHAREHOLDERS EQUITY
Retained Earnings -$138.7M -$135.1M
YoY Change 13.87% 13.76%
Common Stock $108.0K $86.37K
YoY Change 34.42% 64.96%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$2.156M -$4.601M
YoY Change
Total Liabilities & Shareholders Equity $3.664M $2.742M
YoY Change -55.67% -38.19%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income -$4.103M
YoY Change 13.99%
Depreciation, Depletion And Amortization $20.64K
YoY Change -62.09%
Cash From Operating Activities -$2.526M
YoY Change -4.15%
INVESTING ACTIVITIES
Capital Expenditures $53.65K
YoY Change 37.78%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities -$53.65K
YoY Change 37.78%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000
YoY Change -100.0%
NET CHANGE
Cash From Operating Activities -2.526M
Cash From Investing Activities -53.65K
Cash From Financing Activities 0.000
Net Change In Cash -2.580M
YoY Change 12.3%
FREE CASH FLOW
Cash From Operating Activities -$2.526M
Capital Expenditures $53.65K
Free Cash Flow -$2.580M
YoY Change -3.54%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q3 us-gaap Other Assets
OtherAssets
15766 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
145090 usd
CY2023Q3 us-gaap Assets
Assets
8265897 usd
CY2024Q2 us-gaap Assets Current
AssetsCurrent
2129954 usd
CY2023Q3 us-gaap Assets Current
AssetsCurrent
8023716 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
88668 usd
CY2023Q3 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
94062 usd
CY2023Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
154797 usd
CY2024Q2 us-gaap Other Assets
OtherAssets
159244 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
364342 usd
CY2023Q3 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1292861 usd
CY2024Q2 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
116666 usd
CY2024Q2 knwn Amount Due To Related Parties Current
AmountDueToRelatedPartiesCurrent
99692 usd
CY2023Q3 knwn Amount Due To Related Parties Current
AmountDueToRelatedPartiesCurrent
218334 usd
CY2024Q2 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
4539818 usd
CY2023Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
2761931 usd
CY2024Q2 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
105653 usd
CY2024Q2 us-gaap Liabilities Current
LiabilitiesCurrent
6117717 usd
CY2023Q3 us-gaap Liabilities Current
LiabilitiesCurrent
4521985 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4687 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 usd
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
387335 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3746354 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
392022 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-5893762 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-8664827 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8023716 usd
CY2022Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
12593692 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2129954 usd
dei Entity Central Index Key
EntityCentralIndexKey
0001074828
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--09-30
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q3
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2024
CY2023Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000 shares
CY2023Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2023Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
200000000 shares
CY2024Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
86368897 shares
CY2023Q3 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
80358463 shares
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
0 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
0
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0 pure
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2024-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-30262
dei Entity Registrant Name
EntityRegistrantName
KNOW LABS, INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
90-0273142
dei Entity Address Address Line1
EntityAddressAddressLine1
619 Western Avenue
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 610
dei Entity Address City Or Town
EntityAddressCityOrTown
Seattle
dei Entity Address State Or Province
EntityAddressStateOrProvince
WA
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
98101
dei City Area Code
CityAreaCode
206
dei Local Phone Number
LocalPhoneNumber
903-1351
dei Security12b Title
Security12bTitle
Common Stock, par value $0.001 per share
dei Trading Symbol
TradingSymbol
KNW
dei Security Exchange Name
SecurityExchangeName
NYSE
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2024Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
99618897 shares
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2129954 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8023716 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
81325 usd
CY2024Q2 us-gaap Assets
Assets
2742208 usd
CY2024Q2 us-gaap Accounts Payable Trade Current
AccountsPayableTradeCurrent
1255888 usd
CY2024Q2 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
280714 usd
CY2023Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
0 usd
CY2024Q2 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
945258 usd
CY2023Q3 us-gaap Convertible Long Term Notes Payable
ConvertibleLongTermNotesPayable
0 usd
CY2024Q2 us-gaap Liabilities
Liabilities
7343689 usd
CY2023Q3 us-gaap Liabilities
Liabilities
4521985 usd
CY2024Q2 us-gaap Common Stock Value
CommonStockValue
86369 usd
CY2023Q3 us-gaap Common Stock Value
CommonStockValue
80358 usd
CY2024Q2 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
130360164 usd
CY2023Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
125501537 usd
CY2024Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-135050819 usd
CY2023Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-121840788 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-4601481 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3743912 usd
CY2024Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
2742208 usd
CY2023Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
8265897 usd
CY2024Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1348985 usd
CY2023Q2 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1879519 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
5010618 usd
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
6186039 usd
CY2024Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2486846 usd
CY2023Q2 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1359782 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
7025503 usd
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5507511 usd
CY2024Q2 us-gaap Operating Expenses
OperatingExpenses
3835831 usd
CY2023Q2 us-gaap Operating Expenses
OperatingExpenses
3239301 usd
us-gaap Operating Expenses
OperatingExpenses
12036121 usd
us-gaap Operating Expenses
OperatingExpenses
11693550 usd
CY2024Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3835831 usd
CY2023Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-3239301 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-12036121 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-11693550 usd
CY2024Q2 us-gaap Interest Income Other
InterestIncomeOther
30619 usd
CY2023Q2 us-gaap Interest Income Other
InterestIncomeOther
23511 usd
us-gaap Interest Income Other
InterestIncomeOther
126872 usd
us-gaap Interest Income Other
InterestIncomeOther
114325 usd
CY2024Q2 us-gaap Interest Expense
InterestExpense
298248 usd
CY2023Q2 us-gaap Interest Expense
InterestExpense
0 usd
us-gaap Interest Expense
InterestExpense
1038499 usd
us-gaap Interest Expense
InterestExpense
389626 usd
CY2024Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
CY2023Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-384137 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
0 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-384137 usd
CY2024Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-267629 usd
CY2023Q2 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-360626 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-911627 usd
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-659438 usd
CY2024Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-4103460 usd
CY2023Q2 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-3599927 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12947748 usd
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-12352988 usd
CY2024Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2023Q2 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-4103460 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3599927 usd
us-gaap Net Income Loss
NetIncomeLoss
-12947748 usd
us-gaap Net Income Loss
NetIncomeLoss
-12352988 usd
CY2024Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
100045 usd
CY2023Q2 us-gaap Dividends Preferred Stock
DividendsPreferredStock
3337494 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
262283 usd
us-gaap Dividends Preferred Stock
DividendsPreferredStock
3337494 usd
CY2024Q2 knwn Common Stock Dividends On Series D Preferred Stock
CommonStockDividendsOnSeriesDPreferredStock
0 usd
CY2023Q2 knwn Common Stock Dividends On Series D Preferred Stock
CommonStockDividendsOnSeriesDPreferredStock
1627230 usd
knwn Common Stock Dividends On Series D Preferred Stock
CommonStockDividendsOnSeriesDPreferredStock
0 usd
knwn Common Stock Dividends On Series D Preferred Stock
CommonStockDividendsOnSeriesDPreferredStock
1627230 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-4203505 usd
CY2023Q2 us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-8564651 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-13210031 usd
us-gaap Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
-17317712 usd
CY2024Q2 knwn Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.05
CY2023Q2 knwn Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.18
knwn Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.16
knwn Earnings Per Shares Basic And Diluted
EarningsPerSharesBasicAndDiluted
-0.36
CY2024Q2 knwn Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
83038866 shares
CY2023Q2 knwn Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
48928911 shares
knwn Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
82314925 shares
knwn Weighted Average Number Of Shares Outstanding Basic And Diluted
WeightedAverageNumberOfSharesOutstandingBasicAndDiluted
48604274 shares
CY2022Q3 us-gaap Stockholders Equity
StockholdersEquity
9862613 usd
CY2022Q4 knwn Stock Compensation Expense Employee Options
StockCompensationExpenseEmployeeOptions
744640 usd
CY2022Q4 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2343 usd
CY2022Q4 knwn Issuance Of Common Stock For Exercise Of Warrants Amount
IssuanceOfCommonStockForExerciseOfWarrantsAmount
12500 usd
CY2022Q4 knwn Expenses For Extension Of Notes And Warrants
ExpensesForExtensionOfNotesAndWarrants
206994 usd
CY2022Q4 us-gaap Net Income Loss
NetIncomeLoss
-3822859 usd
CY2022Q4 us-gaap Stockholders Equity
StockholdersEquity
7006231 usd
CY2023Q1 knwn Stock Compensation Expense Employee Options
StockCompensationExpenseEmployeeOptions
1182547 usd
CY2023Q1 knwn Expenses For Extension Of Notes And Warrants
ExpensesForExtensionOfNotesAndWarrants
142727 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-4930202 usd
CY2023Q1 us-gaap Stockholders Equity
StockholdersEquity
3401303 usd
CY2023Q2 knwn Stock Compensation Expense Employee Options
StockCompensationExpenseEmployeeOptions
536858 usd
CY2023Q2 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
2344 usd
CY2023Q2 knwn Issuance Of Common Stock For Exercise Of Warrants Amount
IssuanceOfCommonStockForExerciseOfWarrantsAmount
374835 usd
CY2023Q2 knwn Deemed Dividends On Series C And D Preferred Stock Amount
DeemedDividendsOnSeriesCAndDPreferredStockAmount
0 usd
CY2023Q2 knwn Dividend Preferred Stock
DividendPreferredStock
0 usd
CY2023Q2 us-gaap Net Income Loss
NetIncomeLoss
-3599927 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
715413 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
3743912 usd
CY2023Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
3928865 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
262283 usd
us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
3337494 usd
knwn Common Stock Dividends On Series D Preferred Stock
CommonStockDividendsOnSeriesDPreferredStock
0 usd
knwn Common Stock Dividends On Series D Preferred Stock
CommonStockDividendsOnSeriesDPreferredStock
1627230 usd
knwn Warrants Issued For Debt Offering
WarrantsIssuedForDebtOffering
1536743 usd
knwn Warrants Issued For Debt Offering
WarrantsIssuedForDebtOffering
0 usd
CY2023Q4 knwn Stock Compensation Expense Employee Options
StockCompensationExpenseEmployeeOptions
699246 usd
CY2023Q4 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
26250 usd
CY2023Q4 knwn Dividend Preferred Stock
DividendPreferredStock
0 usd
CY2023Q4 knwn Isssuance Of Common Stock For Common Stock Offering Amount
IsssuanceOfCommonStockForCommonStockOfferingAmount
203105 usd
CY2023Q4 us-gaap Net Income Loss
NetIncomeLoss
-3446624 usd
CY2023Q4 us-gaap Stockholders Equity
StockholdersEquity
1225889 usd
CY2024Q1 knwn Stock Compensation Expense Employee Options
StockCompensationExpenseEmployeeOptions
616317 usd
CY2024Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
170760 usd
CY2024Q1 knwn Issuance Of Common Stock For Exercise Of Warrants Amount
IssuanceOfCommonStockForExerciseOfWarrantsAmount
0 usd
CY2024Q1 knwn Dividend Preferred Stock
DividendPreferredStock
0 usd
CY2024Q1 knwn Expenses For Extension Of Notes And Warrants
ExpensesForExtensionOfNotesAndWarrants
594761 usd
CY2024Q1 knwn Issuance Of Shares And Warrants In Connection With Debt Offering Amount
IssuanceOfSharesAndWarrantsInConnectionWithDebtOfferingAmount
1035963 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-5397664 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
-1753974 usd
CY2024Q2 knwn Stock Compensation Expense Employee Options
StockCompensationExpenseEmployeeOptions
1015953 usd
CY2024Q2 knwn Issuance Of Common Stock For Exercise Of Warrants Amount
IssuanceOfCommonStockForExerciseOfWarrantsAmount
0 usd
CY2024Q2 knwn Common Stock Dividends On Series C And D Preferred Stock Amount
CommonStockDividendsOnSeriesCAndDPreferredStockAmount
0 usd
CY2024Q2 knwn Dividend Preferred Stock
DividendPreferredStock
0 usd
CY2024Q2 knwn Issuance Of Common Stock For Debt Payment Amount
IssuanceOfCommonStockForDebtPaymentAmount
240000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
-4103460 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
-4601481 usd
us-gaap Profit Loss
ProfitLoss
-12947748 usd
us-gaap Profit Loss
ProfitLoss
-12352988 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
59009 usd
us-gaap Depreciation And Amortization
DepreciationAndAmortization
259541 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2331516 usd
us-gaap Share Based Compensation
ShareBasedCompensation
2464045 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
277010 usd
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
0 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
0 usd
us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-384137 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
162647 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
96161 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
375859 usd
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
0 usd
us-gaap Interest Expense Other
InterestExpenseOther
594761 usd
us-gaap Interest Expense Other
InterestExpenseOther
349721 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
143478 usd
us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
1999 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-150329 usd
us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-99803 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-133011 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-74866 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-9573764 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-8976051 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
66352 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
80798 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-66352 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-80798 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
3805699 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
0 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
203105 usd
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
262450 usd
us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
0 usd
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
0 usd
knwn Issuance Of Common Stock For Debt Payment
IssuanceOfCommonStockForDebtPayment
240000 usd
knwn Issuance Of Common Stock For Debt Payment
IssuanceOfCommonStockForDebtPayment
0 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2129954 usd
CY2024Q2 knwn Net Working Capital
NetWorkingCapital
3987763 usd
knwn Sell Shares Of Common Stock
SellSharesOfCommonStock
5000000 usd
CY2024Q2 us-gaap Time Deposits At Or Above Fdic Insurance Limit
TimeDepositsAtOrAboveFDICInsuranceLimit
250000 usd
CY2024Q2 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
2103240 usd
CY2023Q3 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
7836393 usd
CY2024Q2 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
86368897 shares
CY2024Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
30072106 shares
CY2024Q2 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
4572000 shares
us-gaap Preferred Stock Dividends Shares
PreferredStockDividendsShares
160000 shares
CY2023Q3 us-gaap Common Stock Other Shares Outstanding
CommonStockOtherSharesOutstanding
52358463 shares
CY2024Q2 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
279683 usd
CY2023Q3 us-gaap Machinery And Equipment Gross
MachineryAndEquipmentGross
213330 usd
CY2024Q2 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
21366 usd
CY2023Q3 us-gaap Furniture And Fixtures Gross
FurnitureAndFixturesGross
21366 usd
CY2024Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
212381 usd
CY2023Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
153371 usd
CY2024Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
88668 usd
CY2023Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
81325 usd
us-gaap Depreciation
Depreciation
59009 usd
us-gaap Depreciation
Depreciation
259541 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
386367 usd
CY2023Q3 us-gaap Operating Lease Liability
OperatingLeaseLiability
154797 usd
CY2024Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
364342 usd
CY2023Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
145090 usd
us-gaap Lease Cost
LeaseCost
120000 usd
us-gaap Lease Cost
LeaseCost
203000 usd
knwn Operatingleaseweighted Average Remaining Lease Term
OperatingleaseweightedAverageRemainingLeaseTerm
P37M
CY2024Q2 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.07 pure
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
126760 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
142755 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
147282 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
12682 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
429478 usd
CY2024Q2 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
43111 usd
CY2024Q2 us-gaap Operating Lease Liability
OperatingLeaseLiability
386367 usd
CY2024Q2 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
5485076 usd
CY2023Q3 us-gaap Debt Instrument Carrying Amount
DebtInstrumentCarryingAmount
2761931 usd
CY2024Q2 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
945258 usd
CY2023Q3 us-gaap Convertible Debt Noncurrent
ConvertibleDebtNoncurrent
0 usd
CY2024Q2 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
4539818 usd
CY2023Q3 us-gaap Convertible Debt Current
ConvertibleDebtCurrent
2761931 usd
CY2024Q2 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
5485076 usd
CY2023Q3 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
2761931 usd
CY2024Q2 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
99692 usd
CY2023Q3 us-gaap Deposit Liabilities Accrued Interest
DepositLiabilitiesAccruedInterest
94062 usd
CY2023 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
230005 usd
knwn Note Shares And Warrant Shares Upon Repayment Or Conversion Of Notes And Exercise Of Warrants Description
NoteSharesAndWarrantSharesUponRepaymentOrConversionOfNotesAndExerciseOfWarrantsDescription
Issuance of Note Shares and Warrant Shares upon repayment or conversion of Notes and exercise of Warrants is subject to an ownership limitation equal to 4.99% of the Company’s outstanding shares of common stock; provided, that if Lind and its affiliates beneficially own in excess of 4.99% of the Company’s outstanding shares of common stock, then such limitation shall automatically increase to 9.99% so long as Lind and its affiliates own in excess of 4.99% of such common stock (and shall, for the avoidance of doubt, automatically decrease to 4.99% upon Lind and its affiliates ceasing to own in excess of 4.99% of such common stock)
us-gaap Interest Expense Debt
InterestExpenseDebt
250000 usd
us-gaap Recapitalization Costs
RecapitalizationCosts
15000000 usd
us-gaap Proceeds From Issuance Of Long Term Debt
ProceedsFromIssuanceOfLongTermDebt
3805699 usd
CY2024Q2 knwn Issuable Upon Conversion Of Common Stock
IssuableUponConversionOfCommonStock
4800000 shares
knwn Warrant Shares
WarrantShares
3000000 shares
knwn Warrant Amount
WarrantAmount
1536743 usd
knwn Securities Purchase Agreement Description
SecuritiesPurchaseAgreementDescription
the Company incurred approximately $994,000 of issuance costs of which $675,971 were allocated to the Note and $318,330 to the Warrant Shares. The amount allocated to the Notes was recorded as debt discount (with an offset to APIC) and is being amortized over the two-year term of the Notes
CY2024Q2 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
275830 usd
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
375859 usd
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
86368897 shares
us-gaap Stock Issued During Period Shares Purchase Of Assets
StockIssuedDuringPeriodSharesPurchaseOfAssets
9020264 shares
CY2024Q1 knwn Description Of Automatic Conversion Of Convertible
DescriptionOfAutomaticConversionOfConvertible
the Company issued 102,302 shares of the Company’s common stock at $0.782 with a total value of $80,000 per share related to a debt offering. The $80,000 was recorded as debt issuance costs and is being amortized over the two-year term of the debt
CY2024Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
3201 shares
knwn Cashless Warrant Exercise
CashlessWarrantExercise
714828 shares
CY2024Q2 knwn Cashless Warrant Exercise
CashlessWarrantExercise
108500 shares
CY2023Q3 knwn Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Numbers
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumbers
20866313 shares
CY2023Q3 knwn Outstanding At Begenning Of Period
OutstandingAtBegenningOfPeriod
1.06
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
6123648 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.79
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
823328 shares
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.25
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
350157 shares
knwn Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInWeightedAverageExercisePrice
0.42
knwn Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Numbe
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumbe
25816476 shares
CY2024Q2 knwn Outstanding At End Of Period
OutstandingAtEndOfPeriod
1.03
srt Federal Funds Sold Average Yield
FederalFundsSoldAverageYield
0 pure
knwn Expected Life Plants Useful Life
ExpectedLifePlantsUsefulLife
P3Y
us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
1.05 pure
us-gaap Short Term Debt Interest Rate Increase
ShortTermDebtInterestRateIncrease
0.0432 pure
us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
25816476 usd
knwn Sharebased Compensation Arrangements By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Vested
SharebasedCompensationArrangementsBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested
1982495 usd
knwn Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Unearned
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodUnearned
17410548 shares
CY2024Q2 us-gaap Shares Issued Price Per Share
SharesIssuedPricePerShare
0.31
CY2024Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions
30072106 shares
knwn Weighted Average Remaining Life Years
WeightedAverageRemainingLifeYears
P3Y8M12D
CY2024Q2 knwn Weighted Average Exercise Price Outstanding
WeightedAverageExercisePriceOutstanding
0.83
CY2024Q2 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions
11082653 shares
CY2024Q2 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1
0.72
srt Federal Funds Sold Average Yield
FederalFundsSoldAverageYield
0 pure
knwn Expected Life Plants Useful Life
ExpectedLifePlantsUsefulLife
P3Y
us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
1.05 pure
knwn Intrinsic Value
IntrinsicValue
2524513 usd
knwn Stock Option Grants
StockOptionGrants
30072106 shares
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 usd
us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0 pure
CY2017Q2 us-gaap Sale Leaseback Transaction Monthly Rental Payments
SaleLeasebackTransactionMonthlyRentalPayments
2908 usd
CY2017Q2 knwn Lease Description
LeaseDescription
The Company vacated the office on May 31, 2024
CY2021Q2 us-gaap Sale Leaseback Transaction Monthly Rental Payments
SaleLeasebackTransactionMonthlyRentalPayments
8697 usd
CY2021Q2 knwn Lease Description
LeaseDescription
the lease was terminated on February 5, 2024
CY2021Q4 us-gaap Sale Leaseback Transaction Monthly Rental Payments
SaleLeasebackTransactionMonthlyRentalPayments
5000 usd
CY2021Q4 us-gaap Lease Expiration Date1
LeaseExpirationDate1
2023-12-31
CY2022Q4 us-gaap Sale Leaseback Transaction Monthly Rental Payments
SaleLeasebackTransactionMonthlyRentalPayments
2250 usd
CY2022Q4 knwn Lease Description
LeaseDescription
The Company expects to vacate the office on May 31, 2024
CY2024Q1 us-gaap Sale Leaseback Transaction Monthly Rental Payments
SaleLeasebackTransactionMonthlyRentalPayments
11492 usd
CY2024Q1 knwn Lease Description
LeaseDescription
increases at 3% annually after year one. The lease commenced on May 1, 2024 and terminates on July 31, 2027
CY2024Q3 us-gaap Class Of Warrant Or Right Unissued
ClassOfWarrantOrRightUnissued
1987500 shares

Files In Submission

Name View Source Status
0001654954-24-010633-index-headers.html Edgar Link pending
0001654954-24-010633-index.html Edgar Link pending
0001654954-24-010633.txt Edgar Link pending
0001654954-24-010633-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
knwn-20240630.xsd Edgar Link pending
knwn_10q.htm Edgar Link pending
knwn_10qimg19.jpg Edgar Link pending
knwn_ex311.htm Edgar Link pending
knwn_ex312.htm Edgar Link pending
knwn_ex321.htm Edgar Link pending
knwn_ex322.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
knwn-20240630_cal.xml Edgar Link unprocessable
knwn-20240630_def.xml Edgar Link unprocessable
knwn-20240630_lab.xml Edgar Link unprocessable
knwn-20240630_pre.xml Edgar Link unprocessable
knwn_10q_htm.xml Edgar Link completed
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
FilingSummary.xml Edgar Link unprocessable